COYA Coya Therapeutics, Inc.
$4.12▲ +4.30%
Healthcare
Other
After hours
$4.12▲ +0.00%
Oct 27, 4:00 PM ET
Volume 55.8K
Avg Volume (10D) 151.9K
Key Metrics & Fundamentals
Market Cap
$96.65M
P/E Ratio
–
Div Yield
0.00%
52W Range
3.71 - 6.77
% vs 50 MA
-11.84%
% vs 200 MA
-11.48%
RSI-14
38.3
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.59
Free Cash Flow
-$8.26M
Gross Rev
$243,745
Gross Profit
$243,745
EBITDA
-$7.04M
COGS
–
Operating Exp
$7.29M
Operating Income
-$7.05M
EBIT
-$7.05M
Pretax Income
-$6.64M
Net Income
-$6.64M
EPS (Diluted)
-0.28
Price & Volume History
Loading chart…
Recent News
Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Business Wire · Oct 14, 2026 8:00 AM ET
Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Business Wire · Oct 13, 2026 8:00 AM ET
Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Business Wire · Oct 5, 2026 8:00 AM ET
Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Business Wire · Sep 15, 2026 8:00 AM ET
Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
Business Wire · Sep 8, 2026 8:00 AM ET
Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Business Wire · Aug 11, 2026 8:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See COYA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.